Latent Tuberculous Infection

Disease-a-Month

Volumn 52, Issue 11-12, 2006, Pages 441-445

  Yun, Joon S ^a   Lazarus, Angeline A ^a   Gilbert, Russell ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID; PROTEINASE INHIBITOR; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; BCG VACCINATION; DIRECTLY OBSERVED THERAPY; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EFFICACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LATENT TUBERCULOUS INFECTION; LIVER TOXICITY; MYCOBACTERIUM TUBERCULOSIS; NEUROPATHY; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; SCREENING TEST; THORAX RADIOGRAPHY; TREATMENT DURATION; TUBERCULIN TEST; TUBERCULOSIS;

ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; BACTERIAL PHYSIOLOGY; FEMALE; HUMANS; ISONIAZID; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PYRAZINAMIDE; RIFAMPIN; RISK FACTORS; TUBERCULOSIS;

EID: 33845196721     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2006.09.009     Document Type: Article

References (6)

1. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161 (2000) S221-S247
2. American Thoracic Society and Centers for Disease Control and Prevention. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 161 (2000) 1376-1395
3. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Controlling Tuberculosis in the United States. Am J Respir Crit Care Med 172 (2005) 1169-1227
4. Blumberg H.M., Leonard Jr. M.K., and Jasmer R.M. Update on treatment of tuberculosis and latent tuberculosis infection. JAMA 293 (2005) 2776-2784
5. Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. MMWR Recomm Rep 52 RR-2 (2003) 15-18
6. American Thoracic Society and Centers for Disease Control and Prevention. Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations-United States, 2001. Am J Respir Crit Care Med 164 (2001) 1319-1320